22 December 2022
Kropz Plc
("Kropz" or the "Company")
Drawdown On New Convertible Equity Facility
Kropz plc (AIM: KRPZ) is pleased to confirm that today it has made its second draw down request under the new ZAR 550 million convertible equity facility from the Company's largest shareholder, ARC Fund ("ZAR 550 Million Equity Facility"), as announced on 14 November 2022.
The second draw down is for ZAR 135 million (approximately US$ 7.9 million). ZAR 107.5 million remains available for drawdown over the term of the ZAR 550 Million Equity Facility.
The next draw down of the ZAR 550 Million Equity Facility is expected to be made on or about 23 January 2023 and monthly thereafter, if required, in line with the terms of the ZAR 550 Million Equity Facility.
ARC Fund has the right, at any time, to convert any outstanding amount under the ZAR 550 Million Equity Facility into new ordinary shares in Kropz Plc.
For further information visit www.kropz.com or contact:
| Kropz Plc |
|
| Mark Summers (CEO) | +27 (0) 79 744 8708 |
|
|
|
| Grant Thornton UK LLP | Nominated Adviser |
| Samantha Harrison Harrison Clarke George Grainger Ciara Donnelly | +44 (0) 20 7383 5100 |
|
| |
| Hannam & Partners | Broker |
| Andrew Chubb Ernest Bell | +44 (0) 20 7907 8500 |
|
|
|
| Tavistock | Financial PR & IR (UK) |
| Nick Elwes Jos Simson Emily Moss | +44 (0) 207 920 3150 kropz@tavistock.co.uk |
|
|
|
| R&A Strategic Communications | PR (South Africa) |
| Charmane Russell | +27 (0) 11 880 3924 charmane@rasc.co.za |
About Kropz Plc
Kropz is an emerging African producer and developer of plant nutrient feed minerals with phosphate projects in South Africa and in the Republic of Congo. The vision of the Group is to become a leading independent phosphate rock producer and to develop into an integrated, mine-to-market plant nutrient company focusing on sub-Saharan Africa.
-ENDS-
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.